September 2025: Updated ADS MAFLD Living Clinical Guideline & Updated Australian Obesity Management Algorithm
Updated ADS Living Clinical Guideline on MAFLD in People with Diabetes The Australian Diabetes Society (ADS) has made important updates to the ADS MAFLD living clinical guideline with respect to […]
August 2025: National Diabetes Research Strategy (2026-2035) & Updated Australian Obesity Management Algorithm
National Diabetes Research Strategy for 2026-2035 A comprehensive strategy to drive impactful, equitable and sustainable diabetes research and improved diabetes care for the benefit of all Australians. The National Diabetes […]
July 2025: Australian Strategy for Foot Health and Disease in Diabetes 2030
New diabetes-related foot disease (DFD) national strategy The Australian Diabetes Society and Diabetes Feet Australia are committed to improving the foot health outcomes for people living with diabetes and in […]
Updated clinical practice recommendations regarding the periprocedural use of GLP-1RAs and GLP-1/GIPRAs (April 2025)
Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have […]
August 2024: New ADS Guideline and Consensus Statement
Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024) A joint guideline by the Australian Diabetes Society (ADS) and Australian and […]
Updated Australian Obesity Management Algorithm
Revised Australian Obesity Management Algorithm The Australian Diabetes Society (ADS) has updated the Australian Obesity Management Algorithm position statement. Download the updated Australian Obesity Management Algorithm Position Statement (July 2024) […]
Clinical Practice Recommendation On Periprocedural Use Of GLP-1/GIP Receptor Agonists (June 2024)
A consensus clinical practice recommendation endorsed by the Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GESA) and Australian and New Zealand College […]
Updated T2D Management Algorithm
Revised Australian Type 2 Diabetes Glycaemic Management Algorithm The Australian Diabetes Society (ADS) has updated the Australian Type 2 Diabetes Glycaemic Management Algorithm diagram to reflect the recent Pharmaceutical Benefits […]
World Diabetes Day 2023
14th November 2023 World Diabetes Day is a global occasion on which people with diabetes, health professionals, diabetes advocates, media, the general public and government organisations unite to raise awareness […]
Roadmap to unite in the fight for change: ADS launches strategic plan 2023-27 with its united partners to reduce diabetes impact
Thank you for joining the conversation during National Diabetes Week. To end the week, we are launching our new strategic plan. The diabetes epidemic is one of the largest and […]